Related Experiment Video
Updated: Feb 24, 2026

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
Published on: April 28, 2023
Obesity as a Conditioning Factor for High-Altitude Diseases
Rocío San Martin1, Julio Brito, Patricia Siques
1Institute of Health Studies, Universidad Arturo Prat, Iquique, Chile.
Obesity increases health risks and economic burdens. This review explores how obesity may worsen high-altitude illnesses by impairing breathing and oxygen levels at high elevations.
Area of Science:
- Environmental Medicine
- Physiology
- Public Health
Background:
- Obesity is a global epidemic linked to chronic diseases like diabetes and cardiovascular conditions.
- Obesity also impacts high-altitude illnesses, including acute mountain sickness and hypoxic pulmonary hypertension.
- The relationship between obesity and high-altitude disease risk is increasingly recognized.
Purpose of the Study:
- To review current literature on the role of obesity in high-altitude illnesses.
- To explore the physiological mechanisms linking obesity to altitude-related health issues.
Main Methods:
- Literature review of existing studies on obesity and high-altitude medicine.
- Analysis of physiological interactions between obesity, metabolism, and hypoxia.
Main Results:
- Obesity exacerbates hypobaric hypoxia at high altitudes.
- Obesity-related metabolic changes and ventilation impairments contribute to hypoxemia.
- Increased risk for high-altitude diseases is observed in overweight individuals.
Conclusions:
- Obesity is a significant conditioning factor for developing high-altitude illnesses.
- Understanding this link is crucial for managing health risks in high-altitude environments.
- Further research is needed to elucidate the complex interactions between obesity and altitude physiology.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
10:17An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Factors Affecting Respiration
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Hyperpnea and Hyperventilation
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion